designLogo

New technology and news

Good Article Sharing

Home page

New Technology Progress

Macromolecular Biopharmaceutical Research*

Macromolecular Biopharmaceutical Research*

Chengdu Tianfu International Biocity was awarded the license and recognized Changrui Biotech as the "public technology platform for carrier drug development and macromolecular biodrug research" in Biocity.

2023-02-02

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

On March 29, 2022, Changrui Biotechnology (Chengdu) Co., Ltd. (hereinafter referred to as "Changrui Biotechnology") was awarded the license by Chengdu Tianfu International Biocity, and recognized Changrui Biotechnology as the "public technology platform for carrier drug development and macromolecule biodrug research" in Biocity.

2023-02-02

< 1 > proceed page

Macromolecular Biopharmaceutical Research*

2023-02-02

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

2023-02-02

CONTACT

Tel：

+86-18008049388 (Manager Liang) +86-19113519820

Address：

1st/6th/7th floor, Building C1, Tianfu International Biological City, Huigu East 1st Road, Shuangliu District, Chengdu

E-mail： Chamray@crcdmo.com

WECHAT

WECHAT

Copyright© CHAMRAY Biotechnology (Chengdu) Co., Ltd. All right reserved

Powered by www.300.cn SEO

License